IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KCK Ltd.

Q3 2023 Holdings

Filed 2023-11-01 | 3 holdings | $70.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Neuropace Inc(NPCE)COM641288105$54.7M5,621,11177.7%
Sight Sciences Inc(SGHT)COM82657M105$15.7M4,646,86622.2%
Aileron Therapeutics Inc(RNTX)COM NEW00887A204$34.0K22,3410.0%